Diana Laura Gonzalez -Tolentino

Ms. Diana Laura Gonzalez -Tolentino

Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, Mexico
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Esli Janai Flores PalmaEsli Janai Flores Palma
Esli Janai Flores Palma
Diana Laura Gonzalez -TolentinoDiana Laura Gonzalez -Tolentino
Diana Laura Gonzalez -Tolentino
Sergio Manuel Manuel Encarnacion-GuevaraSergio Manuel Manuel Encarnacion-Guevara
Sergio Manuel Manuel Encarnacion-Guevara
Jeovanis Gil ValdesJeovanis Gil Valdes
Jeovanis Gil Valdes
RBRamiro Alonso Bastida
Ramiro Alonso Bastida
MVMarco Antonio Leyva Vazquez
Marco Antonio Leyva Vazquez
Background: B-cell acute lymphoblastic leukemia (B-ALL) is the most frequent malignancy of childhood; worldwide, 487,294 new cases and 305,405 deaths were reported in 2022, including more than 5000 new cases in Mexico. Chemotherapy, delivered in induction, consolidation and maintenance phases, remains the mainstay of treatment, yet 10–20% of patients relapse after induction because of chemoresistance, whose molecular basis is still incompletely understood. Methods: This retrospective study aimed to identify proteins associated with resistance to vincristine (VCR) and methotrexate (MTX) administered during the induction phase, using LC–MS/MS proteomics and bioinformatic analysis of treatment-naive bone marrow aspirates from responders and nonresponders. Results: Nonresponders showed a distinct proteomic profile, with deregulated processes converging on cytoskeletal structure and dynamics, nucleic acid metabolism, DNA repair and RNA processing. Within these processes, thymidine phosphorylase (TYMP) and gelsolin (GSN) emerged as differentially expressed proteins, both consistently overexpressed in nonresponders at the individual-patient level. Conclusions: We conclude that cytoskeletal remodeling and nucleotide metabolism are prominent features of intrinsic chemoresistance in pediatric B-ALL, and that TYMP and GSN represent candidate biomarkers of nonresponse to VCR- and MTX-based induction that warrant validation by orthogonal methods in independent, adequately powered cohorts.

26 July 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
Diana Laura Gonzalez -TolentinoDiana Laura Gonzalez -Tolentino
Diana Laura Gonzalez -Tolentino
OGOlga Lilia Garibay-Cerdenares
Olga Lilia Garibay-Cerdenares
Sergio Manuel Manuel Encarnacion-GuevaraSergio Manuel Manuel Encarnacion-Guevara
Sergio Manuel Manuel Encarnacion-Guevara
ÁMÁngel Gabriel Martínez-Batallar
Ángel Gabriel Martínez-Batallar
RBRamiro Alonso Bastida
Ramiro Alonso Bastida
BIBerenice Illades-Aguiar
Berenice Illades-Aguiar
Cervical cancer (CC) affects women worldwide, and more than 95% of cases are caused by persistent infection with high-risk human papillomavirus (HR-HPV), such as type 16, which promotes the progression of precancerous lesions to cancer. This study aimed to identify differentially expressed proteins (DEPs) in biopsies from patients with HPV16+ low-grade squamous intraepithelial lesions (LSILs) and from patients with HPV16+ squamous cell carcinoma (SCC) compared with those from HPV-negative normal cervical tissue (NCT HPV−) controls. The samples were analyzed by high-performance liquid chromatography–tandem mass spectrometry (HPLC-MS/MS) using a data-independent acquisition (DIA) approach. Data processing and differential protein expression analysis were performed with the DIA-NN software (Data-Independent Acquisition Neural Networks), followed by bioinformatics analyses, including Venn diagrams, pathway enrichment, functional interactome, The Cancer Genome Atlas (TCGA)-SCC data integration, and Western blot detection. In total, 1607 DEPs associated with cell adhesion and extracellular matrix proteins were identified in LSILs, whereas 1516 DEPs associated with catalytic and transport activities were identified in SCC; the proteins overexpressed in LSILs (332) were enriched in processes such as metabolism, immune response activation, and stress and cell death responses. In contrast, proteins overexpressed in SCC (205) were associated with the cell cycle, DNA damage, drug metabolism, proteasome degradation, methylation, and immune response. Interaction analyses highlighted proteins related to early proteins 1,5,6 and 7 (E1, E5, E6, and E7). In terms of the two DEPs, S100 calcium binding protein A10 (S100A10/p11) and thymidine phosphorylase (TYMP) were detected in patients with LSIL, HSIL, and SCC at the protein level, consistent with their higher transcript levels in public datasets. Given the small, exploratory cohort, these findings are hypothesis-generating, and validation in a larger, balanced, independent cohort is required. In conclusion, this study identified DEPs associated with the progression of premalignant lesions to SCC that may represent candidate biomarkers and therapeutic targets warranting further investigation.